TY - JOUR
T1 - High burden of prediabetes and diabetes in three large cities in South Asia
T2 - The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study
AU - For the CARRS Surveillance Research Group
AU - Deepa, Mohan
AU - Grace, Mundu
AU - Binukumar, Bhaskarapillai
AU - Pradeepa, Rajendra
AU - Roopa, Shivashankar
AU - Khan, Hassan M.
AU - Fatmi, Zafar
AU - Kadir, Muhammad M.
AU - Naeem, Imran
AU - Ajay, Vamadevan S.
AU - Anjana, Ranjit Mohan
AU - Ali, Mohammed K.
AU - Prabhakaran, Dorairaj
AU - Tandon, Nikhil
AU - Mohan, Viswanathan
AU - Venkat Narayan, K. M.
AU - K Srinath Reddy, Srinath Reddy
AU - Kondal, Dimple
AU - Gupta, Ruby
AU - Sharma, Pragya
AU - Nair, Manisha
AU - Devasenapathy, Nivedita
AU - Pillai, Divya
AU - Gregg, Ed
AU - Merchant, Anwar
AU - Iqbal, Romaina
AU - Pandey, Shivam
AU - Praggya, Naveen
AU - Ramakrishnan, Lakshmy
AU - Savita,
AU - Ramanathan, K.
AU - D'Cruz, Ansel J.
AU - Gnanashekaran, K.
AU - Dorairaj, Mahesh
AU - Rahul, T.
AU - Anthony, J. V.
AU - Arul Dass, A.
AU - Arul Pitchai, S.
AU - Dhanasekar, L.
AU - Kalaivani, D.
AU - Kumar, M.
AU - Nandhakumar, M.
AU - Parthiban, K.
AU - Saravana Kumar, P.
AU - Saravanan, R.
AU - Shenbagavalli, E.
AU - Sivamanikandan, K.
AU - Suresh, T.
AU - Uma Sankari, G.
AU - Gowri,
N1 - Funding Information:
This study is coordinated by CoE-CARRS (Center of Excellence – Center for cArdio-metabolic Risk Reduction in South Asia) based at Public Health Foundation of India (PHFI), New Delhi, India in collaboration with Centre for Chronic Disease Control (CCDC), New Delhi, Emory University, Atlanta, U.S.A, All India Institute of Medical Sciences (AIIMS), New Delhi, Madras Diabetes Research Foundation (MDRF), Chennai, India and Aga Khan University, Karachi, Pakistan. We hereby, acknowledge the contributions of the field and research staff of the “CARRS Surveillance Investigators’ Group”. This project is funded in part by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN268200900026C, and the United Health Group, Minneapolis, MN, USA. Several members of the research team at PHFI, Emory University and CCDC were/are supported by the Fogarty International Clinical Research Scholars-Fellows programme (FICRS-F) through Grant Number 5R24TW007988 from NIH Fogarty International Center (FIC) through Vanderbilt University; D43 NCDs in India Training Program through Award Number D43HD05249 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and FIC; and Wellcome Trust (grant number 096735/ A/11/Z). Ajay was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. However, the contents of this paper are solely the responsibility of the writing group and do not necessarily represent the official views of FIC, Vanderbilt University, Emory University, PHFI, NICHD, or the NIH. This project is funded in part by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN268200900026C, and the United Health Group, Minneapolis, MN, USA.
Funding Information:
Several members of the research team at PHFI, Emory University and CCDC were/are supported by the Fogarty International Clinical Research Scholars-Fellows programme (FICRS-F) through Grant Number 5R24TW007988 from NIH Fogarty International Center (FIC) through Vanderbilt University; D43 NCDs in India Training Program through Award Number D43HD05249 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and FIC; and Wellcome Trust (grant number 096735/A/11/Z). Ajay was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. However, the contents of this paper are solely the responsibility of the writing group and do not necessarily represent the official views of FIC, Vanderbilt University, Emory University, PHFI, NICHD, or the NIH.
Funding Information:
This project is funded in part by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN268200900026C, and the United Health Group, Minneapolis, MN, USA.
Funding Information:
This study is coordinated by CoE-CARRS (Center of Excellence ? Center for cArdio-metabolic Risk Reduction in South Asia) based at Public Health Foundation of India (PHFI), New Delhi, India in collaboration with Centre for Chronic Disease Control (CCDC), New Delhi, Emory University, Atlanta, U.S.A, All India Institute of Medical Sciences (AIIMS), New Delhi, Madras Diabetes Research Foundation (MDRF), Chennai, India and Aga Khan University, Karachi, Pakistan. We hereby, acknowledge the contributions of the field and research staff of the ?CARRS Surveillance Investigators? Group?. This project is funded in part by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN268200900026C, and the United Health Group, Minneapolis, MN, USA. Several members of the research team at PHFI, Emory University and CCDC were/are supported by the Fogarty International Clinical Research Scholars-Fellows programme (FICRS-F) through Grant Number 5R24TW007988 from NIH Fogarty International Center (FIC) through Vanderbilt University; D43 NCDs in India Training Program through Award Number D43HD05249 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and FIC; and Wellcome Trust (grant number 096735/ A/11/Z). Ajay was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. However, the contents of this paper are solely the responsibility of the writing group and do not necessarily represent the official views of FIC, Vanderbilt University, Emory University, PHFI, NICHD, or the NIH. This project is funded in part by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Department of Health and Human Services, under contract no. HHSN268200900026C, and the United Health Group, Minneapolis, MN, USA.
Publisher Copyright:
© 2015 Elsevier Ireland Ltd.
PY - 2015/5/11
Y1 - 2015/5/11
N2 - Aim: To estimate the prevalence of, and assess factors associated with, diabetes and prediabetes in three South Asian cities. Methods: Using a multi-stage cluster random sample representative of each city, 16,288 subjects aged ≥20 years (Chennai: 6906, Delhi: 5365 and Karachi: 4017) were recruited to the Centre for cArdio-metabolic Risk Reduction in South-Asia (CARRS) Study. Fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) were measured in 13720 subjects. Prediabetes was defined as FPG 100-125 mg/dl (5.6-6.9 mmol/l) and/or HbA1c 5.7-6.4% (39-46 mmol/mol) and diabetes as self-report and/or drug treatment for diabetes and/or FPG ≥ 126 mg/dl (≥7.0 mmol/l) and/or HbA1c ≥ 6.5% (48 mmol/mol). We assessed factors associated with diabetes and prediabetes using polytomous logistic regression models. Results: Overall 47.3-73.1% of the population had either diabetes or prediabetes: Chennai 60.7% [95%CI: 59.0-62.4%] (diabetes - 22.8% [21.5-24.1%], prediabetes - 37.9% [36.1-39.7%]); Delhi 72.7% [70.6-74.9%] (diabetes - 25.2% [23.6-26.8%], prediabetes - 47.6% [45.6-49.5%]); and Karachi 47.4% [45.7-49.1%]; (diabetes - 16.3% [15.2-17.3%], prediabetes - 31.1% [29.5-32.8%], respectively). Proportions of self-reported diabetes were 55.1%, 39.0%, and 48.0% in Chennai, Delhi, and Karachi, respectively. City, age, family history of diabetes, generalized obesity, abdominal obesity, body fat, high cholesterol, high triglyceride, and low HDL cholesterol levels were each independently associated with prediabetes, while the same factors plus waist-to-height ratio and hypertension were associated with diabetes. Conclusion: Six in ten adults in large South Asian cities have either diabetes or prediabetes. These data call for urgent action to prevent diabetes in South Asia.
AB - Aim: To estimate the prevalence of, and assess factors associated with, diabetes and prediabetes in three South Asian cities. Methods: Using a multi-stage cluster random sample representative of each city, 16,288 subjects aged ≥20 years (Chennai: 6906, Delhi: 5365 and Karachi: 4017) were recruited to the Centre for cArdio-metabolic Risk Reduction in South-Asia (CARRS) Study. Fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) were measured in 13720 subjects. Prediabetes was defined as FPG 100-125 mg/dl (5.6-6.9 mmol/l) and/or HbA1c 5.7-6.4% (39-46 mmol/mol) and diabetes as self-report and/or drug treatment for diabetes and/or FPG ≥ 126 mg/dl (≥7.0 mmol/l) and/or HbA1c ≥ 6.5% (48 mmol/mol). We assessed factors associated with diabetes and prediabetes using polytomous logistic regression models. Results: Overall 47.3-73.1% of the population had either diabetes or prediabetes: Chennai 60.7% [95%CI: 59.0-62.4%] (diabetes - 22.8% [21.5-24.1%], prediabetes - 37.9% [36.1-39.7%]); Delhi 72.7% [70.6-74.9%] (diabetes - 25.2% [23.6-26.8%], prediabetes - 47.6% [45.6-49.5%]); and Karachi 47.4% [45.7-49.1%]; (diabetes - 16.3% [15.2-17.3%], prediabetes - 31.1% [29.5-32.8%], respectively). Proportions of self-reported diabetes were 55.1%, 39.0%, and 48.0% in Chennai, Delhi, and Karachi, respectively. City, age, family history of diabetes, generalized obesity, abdominal obesity, body fat, high cholesterol, high triglyceride, and low HDL cholesterol levels were each independently associated with prediabetes, while the same factors plus waist-to-height ratio and hypertension were associated with diabetes. Conclusion: Six in ten adults in large South Asian cities have either diabetes or prediabetes. These data call for urgent action to prevent diabetes in South Asia.
KW - CARRS Surveillance
KW - Diabetes
KW - Dysglycemia
KW - Prediabetes
KW - South Asians
KW - Urban
UR - http://www.scopus.com/inward/record.url?scp=84948845766&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2015.09.005
DO - 10.1016/j.diabres.2015.09.005
M3 - Article
C2 - 26432412
AN - SCOPUS:84948845766
SN - 0168-8227
VL - 110
SP - 172
EP - 182
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
IS - 2
ER -